Cubist Systematic Strategies’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.39M Buy
16,900
+2,600
+18% +$205K 0.01% 1779
2025
Q2
$1.15M Buy
14,300
+5,700
+66% +$440K 0.01% 1869
2025
Q1
$690K Sell
8,600
-6,100
-41% -$507K ﹤0.01% 2016
2024
Q4
$1.2M Sell
14,700
-16,000
-52% -$1.33M 0.01% 1686
2024
Q3
$2.53M Sell
30,700
-900
-3% -$67.2K 0.02% 1278
2024
Q2
$2.22M Sell
31,600
-19,600
-38% -$1.4M 0.02% 1257
2024
Q1
$3.79M Sell
51,200
-27,100
-35% -$1.89M 0.02% 1160
2023
Q4
$5.18M Buy
78,300
+7,100
+10% +$444K 0.03% 861
2023
Q3
$4.48M Sell
71,200
-320,200
-82% -$19.9M 0.03% 825
2023
Q2
$22.1M Buy
391,400
+197,100
+101% +$10.9M 0.15% 104
2023
Q1
$11.3M Buy
+194,300
New +$13.1M 0.07% 401

Other funds holding MET

Cubist Systematic Strategies's MET Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of MetLife (MET) in Q3 2025, closing a stake of 499,021 shares — an estimated $39.3M sold.

Cubist Systematic Strategies first reported a position in MET in Q2 2014 and held it in 42 quarters. The position peaked at $40.1M in Q2 2025. 1,363 funds tracked by Wall St. Rank hold MET as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 499,021 MetLife shares in Q3 2025, an estimated $39.3M.
  • Cubist Systematic Strategies first reported a position in MetLife in Q2 2014 and held it in 42 quarters.
  • Cubist Systematic Strategies's MetLife position peaked at $40.1M in Q2 2025.
  • 1,363 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.